Her previous professional history includes working at University College London on a clinical trial called INNOVATE for prostate cancer diagnosis, where she worked to validate new fluidic biomarkers with MRI to improve prostate cancer diagnosis and prognosis. This sparked her interest in the power of pathology and the digital image. She previously worked to develop early-stage novel antibody-drug conjugates for cancer at both University College London and Imperial College London.